Zika vaccine effective in mice
Inovio’s Zika virus vaccine candidate has demonstrated “robust and durable immune responses” in mice, raising hopes for a way to tackle the rapid spread of the disease.
Read MoreAuthor: George Underwood
NICE seeks more evidence for Alexion orphan drug
NICE has published draft guidance for Alexion’s rare disease drug Kanuma (sebelipase alfa), rejecting it in one of its indications and requesting more evidence in another.
Read MoreBreakthrough designations for Roche and AstraZeneca
Roche and AstraZeneca have received breakthrough therapy designations from the US FDA for treatments in multiple sclerosis (MS) and bladder cancer, respectively.
Read MoreBed blocking costs the NHS £900 million a year
‘Bed blocking’, where medically fit patients are unable to leave hospital, could be costing NHS England up to £900 million a year, according to a new review.
Read MoreGlobal cancer hub to open in London
A new global hub for cancer research and treatment is set to be established in London with the aim of accelerating the discovery of new treatments.
Read More- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
